Related Experiment Video
Updated: Oct 20, 2025

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Calcium Chloride Infusions are Not Associated with Improved Outcomes in Neonates Undergoing Cardiac Operations
Laura E Murray1, Holly Burchett1, Shahryar M Chowdhury1
1Department of Pediatrics, Medical University of South Carolina, 10 McClennan Banks Drive, Charleston, SC, 29425, USA.
Insights
Postoperative calcium chloride infusions did not improve cardiac performance in neonates after heart surgery. This study found no reduction in the need for other medications or improved patient outcomes.
Area of Science:
- Cardiology
- Neonatal Medicine
- Pediatric Surgery
Background:
- Neonatal cardiac function relies on myocardial calcium. Limited data exists on calcium chloride infusions in neonates undergoing cardiac surgery.
- Calcium's role in supporting cardiac output in this population requires further investigation.
Purpose of the Study:
- To determine if postoperative calcium chloride infusions reduce the need for inotropic and vasoactive medications in neonates after cardiac surgery.
- To evaluate the impact of calcium chloride on cardiac output and patient outcomes in this cohort.
Main Methods:
- Retrospective cohort study of neonates (≤30 days old) undergoing cardiac surgery between 06/2015 and 12/2018.
- Patients were divided into groups receiving (calcium group) or not receiving (control group) postoperative calcium chloride infusions.
- Primary outcome: maximum Vasoactive Inotropic Score (VIS) > 15 within 24 hours post-surgery.
Main Results:
- No significant difference in maximum VIS > 15 between the calcium group (70%) and control group (55%; p=0.08).
- Similar outcomes observed between groups regarding ventilation duration, enteral feeding time, hospital length of stay, and operative mortality.
- Calcium chloride infusions did not decrease exposure to other vasoactive agents or improve outcomes.
Conclusions:
- Postoperative calcium chloride infusions did not reduce the requirement for inotropic/vasoactive agents in neonates following cardiac surgery.
- The use of calcium chloride infusions did not demonstrate improved clinical outcomes in this patient population.
- Further research may be needed to clarify the role, if any, of calcium chloride in neonatal cardiac surgery care.
Abstract:
Neonatal cardiac performance is dependent on calcium delivery to the myocardium. Little is known about the use and impact of calcium chloride infusions in neonates who undergo cardiac surgery. We hypothesized that the use of calcium chloride infusions would decrease the doses required of traditional inotropic and vasoactive medications by supporting cardiac output in this patient population. We performed a single-institution, retrospective, cohort study. All neonates (≤ 30 days old) undergoing cardiac surgery from 06/01/2015 through 12/31/2018 were included. Patients were divided into two groups: those who received postoperative calcium chloride infusions (calcium group) and those who did not (control group). The primary outcome was the occurrence of a maximum Vasoactive Inotropic Score (VIS) > 15 in the first 24 h following surgery. One hundred and thirty-five patients met inclusion criteria. Sixty-six patients received postoperative calcium infusions and 69 patients did not. Gestational age, weight at surgery, age at surgery, surgical complexity and cardiopulmonary bypass times were similar between groups. Forty-two (70%) patients receiving calcium had a postoperative maximum VIS > 15 compared with 38 (55%) patients not on a calcium infusion (p = 0.08). There were no differences in postoperative length of ventilation, time to enteral feeding, hospital LOS, or operative mortality between groups. Calcium chloride infusions in neonates who underwent cardiac surgery did not decrease exposure to other inotropic and vasoactive agents in the first 24 post-operative hours or improve patient outcomes.
More Related Videos
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Heart Failure Drugs: Inotropic Agents
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Depolarizing Blockers: Pharmocokinetics

